Arrowhead Pharmaceuticals Inc (ARWR) — Cash Flow Reinvestment Rate
Arrowhead Pharmaceuticals Inc (ARWR) has a Cash Flow Reinvestment Rate of 4.27x as of September 2025, reinvesting $87.60 Million (capex $7.49 Million plus investments $80.11 Million) from operating cash flow of $20.49 Million. See Arrowhead Pharmaceuticals Inc (ARWR) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Arrowhead Pharmaceuticals Inc Cash Flow Reinvestment Rate (1997–2025)
Historical reinvestment intensity for Arrowhead Pharmaceuticals Inc across 4 annual periods. For the full cash flow conversion analysis, see Arrowhead Pharmaceuticals Inc cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Arrowhead Pharmaceuticals Inc (1997–2025)
Year-by-year capital reinvestment analysis for Arrowhead Pharmaceuticals Inc. See ARWR free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.85x | $151.96 Million | $179.55 Million | $22.67 Million | ▲ +2.3% |
| 2021 | 0.83x | $141.68 Million | $171.22 Million | $23.57 Million | ▲ +139.6% |
| 2019 | 0.35x | $59.75 Million | $173.03 Million | $12.00 Million | — |
| 1997 | 0.00x | $0.00 | $4.56K | $0.00 | — |